Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injection during stapled hemorrhoidopexy for postoperative outcomes
IRCT20130826014483N12Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of neuronox in hemorrhoid (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Pain intensity at rest, Pain intensity during defecation and 1 more. Started Jun 2025; status: completed.
02
Drugs
neuronox
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on IRCT20130826014483N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130826014483N12.